Centro Hospitalar de Vila Nova de Gaia/Espinho
12
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
UP STUDY - Decipher Persistent Critical Illness Through in Deep Clinical Phenotyping.
Role: collaborator
Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial
Role: collaborator
Transcatheter Mitral and Tricuspid Interventions: a Cardiac Magnetic Resonance Study
Role: collaborator
Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients
Role: collaborator
IUA Committee Research Project on the Management of TASC C and D Aortoiliac Lesions
Role: collaborator
Physical Exercise for Breast Cancer Survivors: Face-to-face Versus Home-based
Role: collaborator
Effects of a Physical Exercise Program in Quality of Life of Breast Cancer Survivors
Role: collaborator
The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA
Role: collaborator
Metformin in the Diastolic Dysfunction of Metabolic Syndrome
Role: collaborator
Does the Preoperative Midazolam Dose Affect Postoperative Pain?
Role: collaborator
Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention in Breast Cancer
Role: collaborator
Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in CAD
Role: collaborator
All 12 trials loaded